FDA Inspection
VitalantVitalant – FDA Inspection, Nov 22, 2024
Record Details
This FDA Inspection record concerns Vitalant, with an inspection on November 22, 2024, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · ef531390-28ec-4538-840b-31ea72884326
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1258010
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Vitalant
6| Date | Classification | Office | Project area |
|---|---|---|---|
| September 5, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 10, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| July 29, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| September 13, 2013 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 15, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Vitalant
- FDA Inspection 1106275 - 2019-09-05
- FDA Inspection 1000905 - 2017-02-10
- FDA Inspection 937619 - 2015-07-29
- FDA Inspection 848182 - 2013-09-13
- FDA Inspection 795373 - 2012-08-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.